These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37431661)

  • 21. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
    Subaiya S; Tabu C; N'ganga J; Awes AA; Sergon K; Cosmas L; Styczynski A; Thuo S; Lebo E; Kaiser R; Perry R; Ademba P; Kretsinger K; Onuekwusi I; Gary H; Scobie HM
    PLoS One; 2018; 13(7):e0199786. PubMed ID: 29965975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new combination vaccine for measles, mumps, rubella and varicella.
    Zareba G
    Drugs Today (Barc); 2006 May; 42(5):321-9. PubMed ID: 16801995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
    Newtonraj A; Vincent A; Selvaraj K; Manikandan M
    Rural Remote Health; 2019 Sep; 19(3):5261. PubMed ID: 31529972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination.
    Rainey JJ; Danovaro-Holliday MC; Magloire R; Kananda G; Lee CE; Chamouillet H; Lacapere F; Mung K; Luman ET
    J Infect Dis; 2011 Sep; 204 Suppl 2():S616-21. PubMed ID: 21954256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Social Mobilization and Community Mobilizers by Non-governmental Health Organizations in Malawi to Support the Eradication of Polio, Improve Routine Immunization Coverage, and Control Measles and Neonatal Tetanus.
    Chimpololo A; Burrowes V
    Am J Trop Med Hyg; 2019 Oct; 101(4_Suppl):85-90. PubMed ID: 31760969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Research protocol of two concurrent cluster-randomized trials: Real-life Effect of a CAMPaign with Measles Vaccination (RECAMP-MV) and Real-life Effect of a CAMPaign with Oral Polio Vaccination (RECAMP-OPV) on mortality and morbidity among children in rural Guinea-Bissau.
    Varma A; Jensen AKG; Thysen SM; Pedersen LM; Aaby P; Fisker AB
    BMC Public Health; 2019 Nov; 19(1):1506. PubMed ID: 31711464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008.
    Lacapère F; Magloire R; Danovaro-Holliday MC; Flannery B; Chamoulliet H; Celestin EP
    J Infect Dis; 2011 Sep; 204 Suppl 2():S698-705. PubMed ID: 21954269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Communication lessons learned from the 2017 measles-rubella campaign in India: perspectives from vaccine decision-makers.
    Limaye RJ; Gupta M; Bansal A; Chandler MK; Santosham M; Erchick DJ
    Health Promot Int; 2022 Oct; 37(5):. PubMed ID: 36287519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection.
    Abbas K; Procter SR; van Zandvoort K; Clark A; Funk S; Mengistu T; Hogan D; Dansereau E; Jit M; Flasche S;
    Lancet Glob Health; 2020 Oct; 8(10):e1264-e1272. PubMed ID: 32687792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Typhoid Vaccine Acceleration Consortium Malawi: A Phase III, Randomized, Double-blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine Among Children in Blantyre, Malawi.
    Meiring JE; Laurens MB; Patel P; Patel P; Misiri T; Simiyu K; Mwakiseghile F; Tracy JK; Masesa C; Liang Y; Henrion M; Rotrosen E; Gmeiner M; Heyderman R; Kotloff K; Gordon MA; Neuzil KM
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S50-S58. PubMed ID: 30845320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vaccination: 1982 status].
    Herzog C; Just M
    Soz Praventivmed; 1982 Sep; 27(4):197-204. PubMed ID: 7136294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns.
    Ho LL; Gurung S; Mirza I; Nicolas HD; Steulet C; Burman AL; Danovaro-Holliday MC; Sodha SV; Kretsinger K
    Int J Infect Dis; 2022 Jun; 119():201-209. PubMed ID: 35398300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decision Making and Implementation of the First Public Sector Introduction of Typhoid Conjugate Vaccine-Navi Mumbai, India, 2018.
    Date K; Shimpi R; Luby S; N R; Haldar P; Katkar A; Wannemuehler K; Mogasale V; Pallas S; Song D; Kunwar A; Loharikar A; Yewale V; Ahmed D; Horng L; Wilhelm E; Bahl S; Harvey P; Dutta S; Bhatnagar P
    Clin Infect Dis; 2020 Jul; 71(Suppl 2):S172-S178. PubMed ID: 32725235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
    Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination coverage and immunity levels against vaccine-preventable diseases in male Air Force recruits in Greece.
    Maltezou HC; Karantoni H; Petrikkos P; Georgota P; Katerelos P; Liona A; Tsagarakis S; Theodoridou M; Hatzigeorgiou D
    Vaccine; 2020 Jan; 38(5):1181-1185. PubMed ID: 31761499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004407. PubMed ID: 32309885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital rubella syndrome: a matter of concern.
    Martínez-Quintana E; Castillo-Solórzano C; Torner N; Rodríguez-González F
    Rev Panam Salud Publica; 2015 Mar; 37(3):179-86. PubMed ID: 25988255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. National programme for the control of poliomyelitis.
    Sokhey J
    Indian J Public Health; 1985; 29(3):168-74. PubMed ID: 3835134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.